Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Newsquawk Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::42589787.png) Newsquawk [@Newsquawk](/creator/twitter/Newsquawk) on x 131.3K followers
Created: 2025-07-18 11:08:49 UTC

🇺🇸US pre-market movers🇺🇸
ES +0.1% NQ +0.1% RTY +0.1%

$NFLX -1.7%: Warned on rising content expenses in Q3 & Q4; Note, EPS & rev. topped w/ strong guidance

$IBKR +5%: Top & bottom line surpassed exp.

$HESS +8%: Wins $XOM arbitration case, paving way for $CVX +4% deal

$MMM +2.5%: EPS & rev. topped w/ strong FY outlook

$SLB +2%: Top & bottom line surpassed Wall St. exp.

$AXP -0.2%: Expenses higher than exp.; EPS & rev. beat alongside reaffirming FY outlook

$TGT -0.2%: To end price matching

$GSK -2%: FDA panel votes against Cos. Blenrep

$NSC +4.5%: UNP is reportedly in early-stage talks to acquire NSC

$TLN +15%: Expands & enhances portfolio with best-in-class CCGTG acquisitions in PJM; deal accretive to cash flow per share by over XX% in 2026


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946165256633430130/c:line.svg)

**Related Topics**
[mmm](/topic/mmm)
[cvx](/topic/cvx)
[ibkr](/topic/ibkr)
[$mmm](/topic/$mmm)
[$cvx](/topic/$cvx)
[$xom](/topic/$xom)
[$hess](/topic/$hess)
[eps](/topic/eps)

[Post Link](https://x.com/Newsquawk/status/1946165256633430130)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Newsquawk Avatar Newsquawk @Newsquawk on x 131.3K followers Created: 2025-07-18 11:08:49 UTC

🇺🇸US pre-market movers🇺🇸 ES +0.1% NQ +0.1% RTY +0.1%

$NFLX -1.7%: Warned on rising content expenses in Q3 & Q4; Note, EPS & rev. topped w/ strong guidance

$IBKR +5%: Top & bottom line surpassed exp.

$HESS +8%: Wins $XOM arbitration case, paving way for $CVX +4% deal

$MMM +2.5%: EPS & rev. topped w/ strong FY outlook

$SLB +2%: Top & bottom line surpassed Wall St. exp.

$AXP -0.2%: Expenses higher than exp.; EPS & rev. beat alongside reaffirming FY outlook

$TGT -0.2%: To end price matching

$GSK -2%: FDA panel votes against Cos. Blenrep

$NSC +4.5%: UNP is reportedly in early-stage talks to acquire NSC

$TLN +15%: Expands & enhances portfolio with best-in-class CCGTG acquisitions in PJM; deal accretive to cash flow per share by over XX% in 2026

XXXXX engagements

Engagements Line Chart

Related Topics mmm cvx ibkr $mmm $cvx $xom $hess eps

Post Link

post/tweet::1946165256633430130
/post/tweet::1946165256633430130